Validity of exchangeable solute balance as a measure of blood volume in neurologically injured adults

Aaron M. Joffe, Lawrence Healey, Nita Khandelwal, Matthew R. Hallman, William Van Cleve, Miriam Treggiari

Research output: Contribution to journalArticle

Abstract

Background: Daily weight (DW) and examination of fluid balances (FB) are commonly used in assessments of extracellular fluid (ECF) and circulating blood volume (BV). We hypothesized that a calculated total body exchangeable solute, the main determinant of the ECF, would have high agreement and correlation with actual BV. Methods: The University of Washington IRB approved the study. We included a sample of consecutive adult patients in whom a BV was measured, while in the neuroscience intensive care units of a large academic medical center. BV was measured as part of routine care using iodinated 131I albumin injection and the BVA-100 (Daxor Corp, New York, NY, USA). Total body exchangeable solute was estimated at the time of BV measurement by multiplying the calculated total body water by the sum of the sodium plus potassium and chloride measured in plasma. The correlation between the change in DW, FB (adjusted for insensible fluid loss), exchangeable solute, and BV was performed using linear regression with adjustment for number of days between admit and BV measurement, and capillary leak. Errors were computed using robust variance estimation. Results: 55 patients had BV tests available, and 43 of them had subarachnoid hemorrhage. Total body exchangeable solute strongly correlated with BV (r = 0.75, 95 % CI 0.63-0.84, p <0.01 for Na+/K+, and r = 0.71, 95 % CI 0.58-0.81, p <0.01 for Cl-). DW (r = 0.21) and FB (r = 0.11) were not correlated with BV. Conclusions: Total body exchangeable solute appears to be a valid and reliable measure of BV and can be calculated using information readily available at the bedside. The value of having this information automatically calculated and available at the bedside should be explored.

Original languageEnglish (US)
Pages (from-to)102-107
Number of pages6
JournalNeurocritical Care
Volume21
Issue number1
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Blood Volume
Water-Electrolyte Balance
Extracellular Fluid
Weights and Measures
Potassium Chloride
Body Water
Research Ethics Committees
Hematologic Tests
Subarachnoid Hemorrhage
Neurosciences
Intensive Care Units
Albumins
Linear Models
Sodium
Injections

Keywords

  • Blood volume
  • Daily weight
  • Exchangeable solute
  • Fluid balance
  • Neurologic injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Validity of exchangeable solute balance as a measure of blood volume in neurologically injured adults. / Joffe, Aaron M.; Healey, Lawrence; Khandelwal, Nita; Hallman, Matthew R.; Van Cleve, William; Treggiari, Miriam.

In: Neurocritical Care, Vol. 21, No. 1, 2014, p. 102-107.

Research output: Contribution to journalArticle

Joffe, Aaron M. ; Healey, Lawrence ; Khandelwal, Nita ; Hallman, Matthew R. ; Van Cleve, William ; Treggiari, Miriam. / Validity of exchangeable solute balance as a measure of blood volume in neurologically injured adults. In: Neurocritical Care. 2014 ; Vol. 21, No. 1. pp. 102-107.
@article{bd52d354fe424f3c879a4e33bc51ef19,
title = "Validity of exchangeable solute balance as a measure of blood volume in neurologically injured adults",
abstract = "Background: Daily weight (DW) and examination of fluid balances (FB) are commonly used in assessments of extracellular fluid (ECF) and circulating blood volume (BV). We hypothesized that a calculated total body exchangeable solute, the main determinant of the ECF, would have high agreement and correlation with actual BV. Methods: The University of Washington IRB approved the study. We included a sample of consecutive adult patients in whom a BV was measured, while in the neuroscience intensive care units of a large academic medical center. BV was measured as part of routine care using iodinated 131I albumin injection and the BVA-100 (Daxor Corp, New York, NY, USA). Total body exchangeable solute was estimated at the time of BV measurement by multiplying the calculated total body water by the sum of the sodium plus potassium and chloride measured in plasma. The correlation between the change in DW, FB (adjusted for insensible fluid loss), exchangeable solute, and BV was performed using linear regression with adjustment for number of days between admit and BV measurement, and capillary leak. Errors were computed using robust variance estimation. Results: 55 patients had BV tests available, and 43 of them had subarachnoid hemorrhage. Total body exchangeable solute strongly correlated with BV (r = 0.75, 95 {\%} CI 0.63-0.84, p <0.01 for Na+/K+, and r = 0.71, 95 {\%} CI 0.58-0.81, p <0.01 for Cl-). DW (r = 0.21) and FB (r = 0.11) were not correlated with BV. Conclusions: Total body exchangeable solute appears to be a valid and reliable measure of BV and can be calculated using information readily available at the bedside. The value of having this information automatically calculated and available at the bedside should be explored.",
keywords = "Blood volume, Daily weight, Exchangeable solute, Fluid balance, Neurologic injury",
author = "Joffe, {Aaron M.} and Lawrence Healey and Nita Khandelwal and Hallman, {Matthew R.} and {Van Cleve}, William and Miriam Treggiari",
year = "2014",
doi = "10.1007/s12028-013-9915-1",
language = "English (US)",
volume = "21",
pages = "102--107",
journal = "Neurocritical Care",
issn = "1541-6933",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Validity of exchangeable solute balance as a measure of blood volume in neurologically injured adults

AU - Joffe, Aaron M.

AU - Healey, Lawrence

AU - Khandelwal, Nita

AU - Hallman, Matthew R.

AU - Van Cleve, William

AU - Treggiari, Miriam

PY - 2014

Y1 - 2014

N2 - Background: Daily weight (DW) and examination of fluid balances (FB) are commonly used in assessments of extracellular fluid (ECF) and circulating blood volume (BV). We hypothesized that a calculated total body exchangeable solute, the main determinant of the ECF, would have high agreement and correlation with actual BV. Methods: The University of Washington IRB approved the study. We included a sample of consecutive adult patients in whom a BV was measured, while in the neuroscience intensive care units of a large academic medical center. BV was measured as part of routine care using iodinated 131I albumin injection and the BVA-100 (Daxor Corp, New York, NY, USA). Total body exchangeable solute was estimated at the time of BV measurement by multiplying the calculated total body water by the sum of the sodium plus potassium and chloride measured in plasma. The correlation between the change in DW, FB (adjusted for insensible fluid loss), exchangeable solute, and BV was performed using linear regression with adjustment for number of days between admit and BV measurement, and capillary leak. Errors were computed using robust variance estimation. Results: 55 patients had BV tests available, and 43 of them had subarachnoid hemorrhage. Total body exchangeable solute strongly correlated with BV (r = 0.75, 95 % CI 0.63-0.84, p <0.01 for Na+/K+, and r = 0.71, 95 % CI 0.58-0.81, p <0.01 for Cl-). DW (r = 0.21) and FB (r = 0.11) were not correlated with BV. Conclusions: Total body exchangeable solute appears to be a valid and reliable measure of BV and can be calculated using information readily available at the bedside. The value of having this information automatically calculated and available at the bedside should be explored.

AB - Background: Daily weight (DW) and examination of fluid balances (FB) are commonly used in assessments of extracellular fluid (ECF) and circulating blood volume (BV). We hypothesized that a calculated total body exchangeable solute, the main determinant of the ECF, would have high agreement and correlation with actual BV. Methods: The University of Washington IRB approved the study. We included a sample of consecutive adult patients in whom a BV was measured, while in the neuroscience intensive care units of a large academic medical center. BV was measured as part of routine care using iodinated 131I albumin injection and the BVA-100 (Daxor Corp, New York, NY, USA). Total body exchangeable solute was estimated at the time of BV measurement by multiplying the calculated total body water by the sum of the sodium plus potassium and chloride measured in plasma. The correlation between the change in DW, FB (adjusted for insensible fluid loss), exchangeable solute, and BV was performed using linear regression with adjustment for number of days between admit and BV measurement, and capillary leak. Errors were computed using robust variance estimation. Results: 55 patients had BV tests available, and 43 of them had subarachnoid hemorrhage. Total body exchangeable solute strongly correlated with BV (r = 0.75, 95 % CI 0.63-0.84, p <0.01 for Na+/K+, and r = 0.71, 95 % CI 0.58-0.81, p <0.01 for Cl-). DW (r = 0.21) and FB (r = 0.11) were not correlated with BV. Conclusions: Total body exchangeable solute appears to be a valid and reliable measure of BV and can be calculated using information readily available at the bedside. The value of having this information automatically calculated and available at the bedside should be explored.

KW - Blood volume

KW - Daily weight

KW - Exchangeable solute

KW - Fluid balance

KW - Neurologic injury

UR - http://www.scopus.com/inward/record.url?scp=84904036592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904036592&partnerID=8YFLogxK

U2 - 10.1007/s12028-013-9915-1

DO - 10.1007/s12028-013-9915-1

M3 - Article

C2 - 24057812

AN - SCOPUS:84904036592

VL - 21

SP - 102

EP - 107

JO - Neurocritical Care

JF - Neurocritical Care

SN - 1541-6933

IS - 1

ER -